|

PDD-TURBT with hexaminolevulinate (Hexvix®) Clinical Trials

1 actively recruiting trial

Also known as: Hexvix®

Pipeline

Phase 4: 1

Top Sponsors

  • University of Roma La Sapienza1

Indications

  • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma1
  • Non-Muscle Invasive Bladder Urothelial Carcinoma1
  • Non-Muscle Invasive Bladder Cancer1
  • Cancer1

Other1 trial

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.